PBMPSYENCE BIOMEDICAL LTD.


$ 0.13 $ -0.03 (-18.59 %)    

Monday, 16-Sep-2024 15:59:35 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 0.127
$ 0.13
$ 0.08 x 500
-- x --
$ 0.12 - $ 0.14
$ 0.12 - $ 4.31
3,014,100
na
1.7M
$ -5.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 psychedelic-biotech-psyence-grows-pipeline-with-trials-and-psilocybin-drug-developer-acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pi...

Core News & Articles

https://www.globenewswire.com/en/news-release/2024/09/16/2946746/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedica...

 psyence-biomed-launches-first-trial-site-in-australia-for-phase-iib-psilocybin-study-in-palliative-care

Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disor...

Core News & Articles

As consideration for the Proposed Acquisition, Psyence Biomed will issue $500,000 of the Company's common shares upon closi...

 psyence-biomedical-pbm-stock-is-down-30-whats-going-on

Psyence Biomedical shares are trading lower by 34% during Wednesday's session. The company announced an exclusive licensing...

Core News & Articles

Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence Biomed" or the "Company") today announced that it has entered in...

 why-psyence-biomedical-pbm-stock-is-skyrocketing

Psyence Biomedical shares are trading higher by 73% during Thursday's session. The company announced the export of nature-d...

Core News & Articles
Psyence Biomedical Shares Resume
07/25/2024 13:40:40

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION